insulin pen
The announcement comes a few months after Medtronic acquired the InPen device's original maker, Companion Medical.
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott's diabetes management platform.
Sanofi's deal with Abbott will be focusing on the diabetes space, while its deal with Happify will be looking at treating MS symptoms using a digital therapeutic.
This morning Glooko also announced that its diasend platform will be compatible with the Dexcom G6.